FGF2 and breast carcinoma: Moreover, it inhibits VEGF and bFGF expression, leading to MVD reduction, and suppresses the synthesis of H-ras protein, consequently halting cancerous cell proliferation and angiogenesis in a mammary carcinoma model induced by DMBA [75].